Huichun C. Su

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical practice guideline for H1 antihistamine-resistant Chronic Spontaneous Urticaria.

Clinical practice guideline for H1 antihistamine-resistant Chronic Spontaneous Urticaria.

Journal: Asian Pacific journal of allergy and immunology

Published: November 03, 2025

Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis.

Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: July 25, 2025

Evaluating the efficacy and safety of biologic and oral drugs for refractory chronic spontaneous urticaria: Systematic review and network meta-analysis.

Evaluating the efficacy and safety of biologic and oral drugs for refractory chronic spontaneous urticaria: Systematic review and network meta-analysis.

Journal: Journal of the American Academy of Dermatology

Published: April 21, 2024

Dupilumab successfully controlled eczema in Wiskott-Aldrich Syndrome over 52 weeks.

Dupilumab successfully controlled eczema in Wiskott-Aldrich Syndrome over 52 weeks.

Journal: Pediatric research

Published: February 04, 2024

Successful treatment of classic Kaposi sarcoma with Trichophyton rubrum-infected onychomycosis and tinea pedis utilizing combination of oral itraconazole and thalidomide.

Successful treatment of classic Kaposi sarcoma with Trichophyton rubrum-infected onychomycosis and tinea pedis utilizing combination of oral itraconazole and thalidomide.

Journal: The Journal of dermatology

Published: September 07, 2023

Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta.

Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta.

Journal: European journal of dermatology : EJD

Published: August 18, 2023

Comparative efficacy and safety of JAK/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis.

Comparative efficacy and safety of JAK/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis.

Journal: Indian journal of dermatology, venereology and leprology

Published: July 31, 2023

A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity.

A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: May 01, 2023

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab.

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab.

Journal: JAAD case reports

Published: January 30, 2023

Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis.

Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis.

Journal: Journal of autoimmunity

Published: January 17, 2023

One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2.

One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2.

Journal: Allergy

Published: September 26, 2022

The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why.

The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 17, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026